A recent study published in the July 11, 2012 edition of the Journal of the American college of Cardiology confirmed that the way HDL, the "good cholesterol," is evaluated in clinical practice is not that meaningful. Currently most doctors evaluate how much cholesterol each HDL protein is carrying. It is more significant to measure the number of HDL protein particles and sizes than the amount of cholesterol these particles contain. These tests currently can be done by specialty labs such as Spectracell and Berkeley Heart Lab. At the end of May I attended the 2012 Institute for Functional Medicine's annual symposium. This year the topic was on Cardiometabolic diseases, which include heart disease and diabetes. The way HDL and LDL are measured and evaluated was discussed in detail, with the recommendation to evaluate particle size and number.
Please visit my web site at www.drjessicaseaton.com
No comments:
Post a Comment